Last updated on January 2019

Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis


Brief description of study

To explore the efficacy and pharmacodynamic effects of omiganan topical gel in facial seborrheic dermatitis.

Clinical Study Identifier: NCT03688971

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.